本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

39.78
+0.13000.33%
盘后39.780.00000.00%19:45 EDT
成交量:264.48万
成交额:1.04亿
市值:75.53亿
市盈率:-11.25
高:39.82
开:38.96
低:38.57
收:39.65
数据加载中...
2020/02/19

重要事件披露

Current report, item 5.02
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/07

重要事件披露

Current report, item 1.01
2019/12/26

重要事件披露

Current report, items 2.02 and 9.01
2019/12/17

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2019/11/20

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/11/19

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/11/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/15

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/11

重要事件披露

Current report, item 5.02
2019/09/12

重要事件披露

Current report, items 1.01, 7.01, and 9.01
2019/08/14

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/08

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/11

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/07/10

超过5%披露

General statement of acquisition of beneficial ownership
2019/07/09

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/08

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/08

超过5%披露

General statement of acquisition of beneficial ownership